Tuberculosis and other Highly Infectious Respiratory Pathogens
Description: Mycobacterium tuberculosis (Mtb) is one of the most ubiquitous pathogens in the world. Approximately 1.5 million people die of tuberculosis (TB), and eight to ten million new cases of active TB occur each year. The existing vaccine against Mtb is ineffective. Developing new strategies to eradicate TB requires an in-depth understanding of the intimate interplay between Mtb and host immunity. The success of Mtb is closely linked to its ability to subvert the immune response to benefit its survival. Immune evasion tactics used by Mtb likely limit the efficacy of vaccines developed to date. Therefore, elucidating the mechanisms exploited by Mtb to evade the immune response may provide new insights into TB pathogenesis and contribute to the development of effective vaccines and therapies. The bone marrow (BM) is a critical site of hematopoiesis by which hematopoietic stem cells (HSC) differentiate into immune cells. I have recently demonstrated that Mtb in the BM reprograms HSCs and suppresses myelopoiesis to subvert the immunity to TB. However, how Mtb reprograms the HSCs and generates detrimental immunity is completely unknown. The BM niche is a specialized microenvironment, where a complex and dynamic network of interaction across multiple cell types regulates HSCs function and behavior. Therefore, it is no surprise that changes in the BM niche could play an important role in determining the outcome of the immune response against infectious diseases such as TB. The overall goal of my proposed studies is to dissect the cross-talk between BM niche cells and HSCs and its impact on the outcome of the immune response against TB. In my first aim, I would like to investigate how the persistence of Mtb in the BM modulates the niche and its consequences on the HSC's function. With aging, the immune system undergoes significant age-related changes. Therefore, the classical approaches to designing vaccines against TB would not be very effective for the elderly host. Targeted therapies for the elderly spurred by a greater understanding of their changing immune responses are highly warranted. BM niche cells' contribution to aged HSC's function at a steady state is well studied, their role in stress-driven hematopoiesis during chronic infection is incompletely understood. Therefore, my second aim is to identify the effect of aged BM niche on hematopoiesis in response to Mtb and its consequences on the immunity of elderly hosts against TB.
Amount: CA$600,000
Funding type: fellowship
Funder scheme: Canada Research Chairs - CIHR Funded - Tier 2
Start date: 2023-04-01
End date: 2028-03-31
Investigator: Nargis Khan (lead)
Institution: University of Calgary
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Funded outputs count: 0
Funder award ID: 189586_1
OpenAlex ID: G5568740043
